Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Joi C. Hester"'
Autor:
Guillermo E. Umpierrez, Georgia Davis, Barbara McLean, Shivani Agarwal, Kathleen Dungan, Citlalli Perez-Guzman, Francisco J. Pasquel, Marina Rabinovich, Limin Peng, Eileen R Faulds, Norma Poindexter, Tara Walker, Joi C. Hester, Debbie Vigliotti, Patricia Hannon, Seema S. Tekwani, Petrena Saunders, Greg S. Martin
Publikováno v:
Diabetes Care
OBJECTIVE The use of remote real-time continuous glucose monitoring (CGM) in the hospital has rapidly emerged to preserve personal protective equipment and reduce potential exposures during coronavirus disease 2019 (COVID-19). RESEARCH DESIGN AND MET
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8dafa7c81ab92c8a8f8a2d931dac6d5c
https://doi.org/10.2337/dc20-2085
https://doi.org/10.2337/dc20-2085
Autor:
Seema S. Tekwani, Georgia Davis, Francisco J. Pasquel, Joi C. Hester, Marina Rabinovich, Norma Poindexter
Publikováno v:
Diabetes. 70
Introduction: During the COVID-19 pandemic, we implemented a protocol combining continuous glucose monitoring (CGM) with a computerized intravenous insulin infusion algorithm to care for patients with severe COVID-19. Objective: To examine glucose tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2e52857b6b136ae7a2a3fda4f8546b0
https://doi.org/10.2337/db21-74-lb
https://doi.org/10.2337/db21-74-lb
Autor:
Stacy Zimmerman, Joshua Liu, Francisco J. Pasquel, Wesley Cunningham, Suporn Sukpraprut-Braaten, Teresa Nimmo, Joi C. Hester
Publikováno v:
Endocrine Practice. 27:S25-S26
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33e70cfc71719fe70d620d37461a7fec
https://doi.org/10.1016/j.eprac.2021.04.524
https://doi.org/10.1016/j.eprac.2021.04.524
Autor:
Suporn Sukpraprut-Braaten, Seth Coleman, Stephanie Igtiben, Teresa Nimmo, Francisco J. Pasquel, Joi C. Hester, Stephen Wagner
Publikováno v:
Endocrine Practice. 27:S24-S25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0a1b5681c4d10cafa913e28d963c9876
https://doi.org/10.1016/j.eprac.2021.04.522
https://doi.org/10.1016/j.eprac.2021.04.522
Autor:
Joshua Liu, Francisco J. Pasquel, Stacy Zimmerman, Wesley Cunningham, Teresa Nimmo, Joi C. Hester, Suporn Sukpraprut-Braaten
Publikováno v:
Journal of the Endocrine Society
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are cardiorenal protective agents increasingly used in patients with diabetes. Cases of euglycemic diabetic ketoacidosis (euDKA) have been reported particularly among patients with type 1 diabetes. O
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::deb56c6ae1a3d0c25ae65e08e31d9c77
http://europepmc.org/articles/PMC8089890
http://europepmc.org/articles/PMC8089890